Skip to main content
2025 PharmSci 360 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Formulation and Delivery
Hot Topic

Hot Topic: Rise of Machines and Biosensors in Drug Delivery

Monday, November 10, 2025
9:30 AM - 10:30 AM CT
Location:220

Formulation and Delivery Hot Topic

    Hot Topic Moderator(s)

  • Vivek Agrahari, PhD (he/him/his)

    Sr. Scientist, Pharmaceutical R&D, Product Development Lead
    CONRAD / Macon & Joan Brock Virginia Health Sciences at Old Dominion University
    Norfolk, Virginia

    • Hot Topic Speaker(s)

  • Minjun Kim, PhD

    Robert C. Womack Endowed Chair Professor in Engineering
    Southern Methodist University

  • Karthik Raman, PhD (he/him/his)

    CEO
    Persist AI Formulations Corp
    West Sacramento, California

Machines and biosensors are transforming biomedical applications, including disease diagnosis, treatment, remote monitoring, and precise drug delivery. Advanced technologies, such as robotic devices, MEMS, microfluidics, wireless drug delivery systems, smart pills, and implants, are driving the development of innovative therapeutic solutions. The integration of AI is further advancing these technologies, enabling autonomous control and optimization in treating various indications with increasing interest in personalized medicine. This proposal outlines the therapeutic applications of machines and biosensors, focusing on the integration of AI, their fabrication, scale-up, analysis, translational challenges, and limitations of clinical adoptions. It highlights key design factors for effective therapy, like patient safety, personalized medicine, and regulatory compliance. The goal is to bring together scientists to review current research, identify essential design elements, and find areas for further improvement. Ultimately, the proposal aims to advance the clinical application of machine and biosensor-based devices in various therapeutic fields.

Learning Objectives:

  • Upon completion, participant will be able to analyze the role of machines and biosensors in improving biomedical applications, including disease diagnosis, treatment, and targeted drug delivery
  • Upon completion, participant will be able to assess the impact of AI integration on developing personalized and autonomous therapeutic solutions.
  • Upon completion, participant will be able to identify key design factors and development challenges in the fabrication and clinical translation of machine and biosensor-based therapeutic platforms.